Evidence map›Paper›PMID 31101744›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2019

In Vivo Synaptic Density Imaging with

Takuya Toyonaga, Levi M Smith, Sjoerd J Finnema, Jean-Dominique Gallezot, Mika Naganawa, Jason Bini, Tim Mulnix, Zhengxin Cai, Jim Ropchan, Yiyun Huang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  7. Assessing non-invasive quantitative methods for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  8. Article
  9. Molecular connectivity studies in neurotransmission: a scoping review.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  10. Review
  11. Article
  12. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  13. Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  14. Article
  15. Dual Drug Repurposing: The Example of Saracatinib.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Longitudinal Synaptic Loss in Primary Tauopathies: An In Vivo [Movement disorders : official journal of the Movement Disorder Society · 2023
    Observational
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Takuya ToyonagaPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut takuya.toyonaga@yale.edu.
Levi M SmithDepartment of Cell Biology, Yale University School of Medicine, New Haven, Connecticut.
Sjoerd J FinnemaPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Jean-Dominique GallezotPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Mika NaganawaPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Jason BiniPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Tim MulnixPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Zhengxin CaiPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Jim RopchanPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Yiyun HuangPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Stephen M StrittmatterProgram in Cellular Neuroscience, Neurodegeneration, and Repair, Yale University School of Medicine, New Haven, Connecticut; and.
Richard E CarsonPET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Prion Protein in Alzheimer's Disease PathophysiologyR01AG034924 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2010 to 2026
$9.6M
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's DiseaseU01AG058608 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2018 to 2022
$8.5M
Yale Alzheimer Disease Research CenterP50AG047270 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2015 to 2019
$8.3M
Characterizing and Targeting Pyk2 Kinase in Alzheimer’s DiseaseRF1AG053000 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2016 to 2016
$2.1M
State-of-the-Art Small Animal PET/CT InstrumentationS10OD010322 · OD · YALE UNIVERSITY · PI CARSON, RICHARD E. · 2013 to 2013
$595k
NCATS NIH HHS UL1 TR000142NCATS NIH HHS UL1 TR001863NIA NIH HHS P50 AG047270NIA NIH HHS R01 AG034924NIA NIH HHS RF1 AG053000NIA NIH HHS U01 AG058608NIH HHS S10 OD010322
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Positron-Emission TomographyPyridinesPyrrolidinesAlzheimer DiseaseAnimalsBenzodioxolesDisease Models, AnimalFemaleKineticsMaleMicePyrrolidinonesQuinazolinesSynapses1-((3-(methylpyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-oneBenzodioxolesPyridinesPyrrolidinesPyrrolidinonesQuinazolinessaracatinib11C-UCB-J PETAlzheimer diseasesaracatinib (AZD0530)SV2Asynaptic density

Identifiers

PMID31101744
PMCPMC6894376
OpenAlexW2945441952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.